YU42166B - Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid - Google Patents

Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid

Info

Publication number
YU42166B
YU42166B YU1917/78A YU191778A YU42166B YU 42166 B YU42166 B YU 42166B YU 1917/78 A YU1917/78 A YU 1917/78A YU 191778 A YU191778 A YU 191778A YU 42166 B YU42166 B YU 42166B
Authority
YU
Yugoslavia
Prior art keywords
amino
obtaining
crystalline form
cephalosporanic acid
oxime derivative
Prior art date
Application number
YU1917/78A
Other languages
English (en)
Other versions
YU191778A (en
Inventor
G Amiard
D Bormann
W Duerckheimer
J Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU42166(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority to SI7811917A priority Critical patent/SI7811917A8/sl
Publication of YU191778A publication Critical patent/YU191778A/xx
Publication of YU42166B publication Critical patent/YU42166B/xx
Priority to HRP-1917/78A priority patent/HRP931395B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU1917/78A 1977-08-17 1978-08-10 Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid YU42166B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI7811917A SI7811917A8 (en) 1977-08-17 1978-08-10 Process for obtaining the crystaline form of the sodium salt of oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid
HRP-1917/78A HRP931395B1 (en) 1977-08-17 1993-11-11 Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
YU191778A YU191778A (en) 1983-02-28
YU42166B true YU42166B (en) 1988-06-30

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1917/78A YU42166B (en) 1977-08-17 1978-08-10 Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid

Country Status (34)

Country Link
US (1) US4224371A (xx)
EP (1) EP0001024B1 (xx)
JP (1) JPS5441890A (xx)
AT (2) AT366049B (xx)
AU (1) AU520898B2 (xx)
BG (2) BG33887A3 (xx)
CA (1) CA1121343A (xx)
CS (2) CS207646B2 (xx)
DD (1) DD137588A5 (xx)
DE (1) DE2860358D1 (xx)
DK (2) DK152213C (xx)
EG (1) EG13520A (xx)
ES (1) ES472381A1 (xx)
FI (1) FI65433C (xx)
FR (1) FR2400519A1 (xx)
GE (2) GEP19960475B (xx)
GR (1) GR73661B (xx)
HR (1) HRP931395B1 (xx)
HU (1) HU181497B (xx)
IE (1) IE47230B1 (xx)
IL (1) IL55186A (xx)
IT (1) IT1107961B (xx)
MD (2) MD247C2 (xx)
MX (2) MX155976A (xx)
NO (1) NO156168C (xx)
NZ (1) NZ188163A (xx)
OA (1) OA06016A (xx)
PL (1) PL126619B1 (xx)
PT (1) PT68431A (xx)
RO (1) RO79999A (xx)
SI (1) SI7811917A8 (xx)
SU (2) SU799666A3 (xx)
YU (1) YU42166B (xx)
ZA (1) ZA784187B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
WO1987001117A2 (en) * 1985-08-12 1987-02-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
DK152213B (da) 1988-02-08
CA1121343A (fr) 1982-04-06
DK163514C (da) 1992-07-27
IE781669L (en) 1979-02-17
MX5448E (es) 1983-08-09
EP0001024A1 (fr) 1979-03-07
NO156168B (no) 1987-04-27
PT68431A (fr) 1978-09-01
DK163514B (da) 1992-03-09
NO782782L (no) 1979-02-20
ZA784187B (en) 1979-09-26
PL126619B1 (en) 1983-08-31
FI782494A (fi) 1979-02-18
ATA52280A (de) 1981-07-15
ES472381A1 (es) 1979-03-16
JPS5441890A (en) 1979-04-03
DK159786A (da) 1986-04-09
MD225C2 (ro) 1995-12-31
US4224371A (en) 1980-09-23
MD247C2 (ro) 1995-12-31
NO156168C (no) 1987-08-19
IT1107961B (it) 1985-12-02
MX155976A (es) 1988-06-06
GR73661B (xx) 1984-03-28
MD247B1 (ro) 1995-07-31
OA06016A (fr) 1981-06-30
GEP19960476B (en) 1996-07-22
AT366050B (de) 1982-03-10
IE47230B1 (en) 1984-01-25
RO79999A (ro) 1982-10-11
ATA563578A (de) 1981-07-15
DK159786D0 (da) 1986-04-09
DK152213C (da) 1988-07-11
PL209080A1 (pl) 1979-06-04
IL55186A (en) 1981-07-31
DK361078A (da) 1979-02-18
FI65433B (fi) 1984-01-31
FI65433C (fi) 1984-05-10
AU520898B2 (en) 1982-03-04
EP0001024B1 (fr) 1981-01-21
SU852175A3 (ru) 1981-07-30
BG33887A3 (en) 1983-05-16
DD137588A5 (de) 1979-09-12
GEP19960475B (en) 1996-07-22
JPS6145626B2 (xx) 1986-10-08
BG33888A3 (en) 1983-05-16
NZ188163A (en) 1981-10-19
AT366049B (de) 1982-03-10
CS207646B2 (en) 1981-08-31
AU3896578A (en) 1980-02-21
HU181497B (en) 1983-07-28
SI7811917A8 (en) 1997-12-31
DE2860358D1 (en) 1981-03-12
YU191778A (en) 1983-02-28
SU799666A3 (ru) 1981-01-23
HRP931395B1 (en) 1996-04-30
FR2400519B1 (xx) 1980-05-16
IT7850648A0 (it) 1978-08-08
EG13520A (en) 1982-03-31
CS207647B2 (en) 1981-08-31
IL55186A0 (en) 1978-09-29
MD225B1 (ro) 1995-06-30
FR2400519A1 (fr) 1979-03-16

Similar Documents

Publication Publication Date Title
GR65303B (en) Process for preparation of phthalazin-4-ylacetic acid derivatives
RO75478B (ro) Procedeu pentru prepararea unor derivati ai acidului alfa-fenoxipropionic
YU52278A (en) Process for obtaining substituted pyridylmethylesters of cyclopropane-carboxylic acid
PT68294A (en) Process for the preparation of substituted naphthyridinones
YU42166B (en) Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid
JPS5419913A (en) Alphaahalomethyl derivative of alphaaamino acid
GB2012761B (en) Oxime derivatives of 3-substituted-7-amino-thiazolyl-acetamido-cephalosporanic acid
JPS5414916A (en) Alphaaacetylene derivative of alphaaamino acid
PH14288A (en) Improved process for the preparation of thienopyridine derivative
BG30472A1 (en) Method for obtaining of derivatives of 2- pyridil- , respectively of 2- pyrimidil- aminobensoic acid
YU41583B (en) Process for obtaining new oxime derivatives of 3-thiadiazolyl-thiomethyl-7-amino-thiazolyl acetamido cephalospornic acid
PT68480A (en) Process for the preparation of herbicidal phosphonates
YU297976A (en) Process for preparing the crystalline from of the cefacetrial sodium salt
PT68479A (en) Process for the preparation of herbicidal phosphonates
IL54206A0 (en) Process for the preparation of , -dialkoxycarboxylic acid derivatives
GB1540783A (en) Crystalline potassium salt of beta-nicotinamide-adenine-dinucleotide-phosphoric acid
YU135378A (en) Process for the manufacture of new piperazine-dithiocarboxylic acid derivatives
IL52021A0 (en) Process for the preparation of an acetonitrile derivative
BE871068A (fr) Nouveau procede de preparation de 4-chloroquinoleines
GB2005660B (en) Oxime derivatives of 7-amino-thiazolyl-acetamido-cephalosporanic acid
HU184750B (en) Process for the preparation of d-diammonium salt of oxa-beta-lactam-dicarboxylic acid antibiotic
JPS5392744A (en) Derivative of omegaaaryloxyy133 prostin acid
BE866711A (fr) Procede de preparation de composes organo-stanniques
DE2860907D1 (en) Process for the preparation of hydroxylammonium salts
GR65659B (en) Method for preparation of derivatives of cloroulanic acid